A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy.
Sio Teng LamHe HuangXiaojie FangZhao WangHuangming HongQuanguang RenYing TianSuxia LinTongyu LinPublished in: Cancer management and research (2020)
This study is the first to validate the prognostic value of nPD-L1 and tumor-infiltrating FoxP3+Tregs in ENKTL; the new immunological prognostic model might be used to stratify ENKTL patients in clinical trials for new therapeutic strategies.